YY1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.348100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.029600E-01
Normal-vs-Stage2
1.123650E-02
Normal-vs-Stage3
3.193200E-01
Normal-vs-Stage4
1.992600E-01
Stage1-vs-Stage2
5.241800E-01
Stage1-vs-Stage3
2.820400E-01
Stage1-vs-Stage4
1.333030E-01
Stage2-vs-Stage3
1.032760E-01
Stage2-vs-Stage4
1.052610E-01
Stage3-vs-Stage4
8.806000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.311700E-02
Normal-vs-AfricanAmerican
7.266600E-01
Normal-vs-Asian
9.063000E-01
Caucasian-vs-AfricanAmerican
8.532000E-01
Caucasian-vs-Asian
5.176000E-01
AfricanAmerican-vs-Asian
8.335600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.954160E-02
Normal-vs-Female
2.002600E-01
Male-vs-Female
3.309800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.620200E-01
Normal-vs-Age(41-60Yrs)
8.840600E-04
Normal-vs-Age(61-80Yrs)
3.471200E-01
Normal-vs-Age(81-100Yrs)
7.208800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.457800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.750200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.759200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.063650E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.861240E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.943400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.339200E-01
Normal-vs-Daily Drinker
8.327600E-01
Normal-vs-Weekly Drinker
8.001200E-01
Normal-vs-Occasional Drinker
2.361700E-02
Normal-vs-Social Drinker
6.836000E-01
Non Drinker-vs-Daily Drinker
9.886200E-01
Non Drinker-vs-Weekly Drinker
9.770800E-01
Non Drinker-vs-Occasional Drinker
5.660300E-02
Non Drinker-vs-Social Drinker
6.952200E-01
Daily Drinker-vs-Weekly Drinker
9.735000E-01
Daily Drinker-vs-Occasional Drinker
1.277190E-01
Daily Drinker-vs-Social Drinker
7.303400E-01
Weekly Drinker-vs-Occasional Drinker
1.377990E-01
Weekly Drinker-vs-Social Drinker
7.616800E-01
Occasional Drinker-vs-Social Drinker
1.529190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.305600E-01
Normal-vs-Grade 2
1.293730E-02
Normal-vs-Grade 3
1.556420E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.099700E-03
Grade 1-vs-Grade 3
3.976700E-03
Grade 1-vs-Grade 4
1.305600E-01
Grade 2-vs-Grade 3
3.736400E-01
Grade 2-vs-Grade 4
1.293730E-02
Grade 3-vs-Grade 4
1.556420E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.917200E-01
Normal-vs-NonDiabetic
7.317800E-02
Diabetic-vs-NonDiabetic
6.078600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.655800E-01
Normal-vs-NoPancreatitis
4.518100E-02
Pancreatitis-vs-NoPancreatitis
5.306300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.873000E-01
Normal-vs-N1
5.921500E-03
N0-vs-N1
6.280300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.41839999999672E-05
Normal-vs-TP53-NonMutant
9.800800E-01
TP53-Mutant-vs-TP53-NonMutant
3.84500000000232E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
